SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 188 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $227,000 | -60.1% | 25,197 | -47.0% | 0.01% | -58.1% |
| Q2 2021 | $569,000 | +4.4% | 47,528 | +9.3% | 0.03% | 0.0% |
| Q1 2021 | $545,000 | +9.9% | 43,467 | +36.6% | 0.03% | -13.9% |
| Q4 2020 | $496,000 | +89.3% | 31,813 | +14.7% | 0.04% | +300.0% |
| Q3 2020 | $262,000 | -67.4% | 27,733 | -69.1% | 0.01% | -57.1% |
| Q2 2020 | $804,000 | +318.8% | 89,765 | +197.6% | 0.02% | +320.0% |
| Q1 2020 | $192,000 | -78.7% | 30,168 | -71.9% | 0.01% | -61.5% |
| Q4 2019 | $900,000 | – | 107,542 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |